4.7 million Euro and two ERC Advanced Grants for Stefanie Dimmeler and Andreas Zeiher

The European Research Council supports the projects of Stefanie Dimmeler and Andreas Zeiher with a total of 4.7 million euro for their high-risk projects aiming towards scientific breakthroughs. Stefanie Dimmeler receives the grant already for the third time. The exploration of the following topics will be funded for the next five years:

 

Neuroheart (Stefanie Dimmeler): As aging is a major risk factor for cardiovascular disease, knowledge about mechanisms underlying age-related changes is still scarce. In this project the unique interaction of nerves and vessels in the aging heart will be studied, which likely contributes to the development of age-related diseases of the heart muscle. The long-term goal is to lay the foundation for the development of therapies that contribute to healthy aging of the heart.

 CHIP-AVS (Andreas Zeiher): The most common acquired heart valve disease is degenerative aortic valve stenosis. In this disease, the valve tissue is thickened and calcified. CHIP mutations in white blood cells might play a role in this process and will be characterized more precisely in the project. The goals are to discover prognostic biomarkers and to identify starting points for possible therapies.

 

 

 

ERC Advanced Grants are part of the main ERC frontier research grants 2022 funded by the European Union’s Horizon Europe Framework Programme (HE FP) for Research and Innovation. The ERC’s main frontier research grants aim to empower individual researchers and provide the best settings to foster their creativity. Scientific excellence is the sole criterion of evaluation.

More information here: ERC Frontier Research Grants